Asia Pacific Biobanks Market – Size, Trends and Forecast (2024 – 2032)

A biobank is a type of biorepository which stores the biological samples, usual humans for use in future research.These biobanks play a vital role in drug discovery and disease research. Biobanks give access to samples which are collected by doctors for their research studies. These storages may range from the refrigerator to warehouse, hospitals, universities and pharmaceutical companies.

The Asia Pacific Biobanks MarketSegments Size & Growth:

The Asia Pacific BiobanksMarket is accounted for $38billion in 2017 and expected to grow at a CAGR of 11% to reach $62 billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth due to rapid growth in population increase in chronic diseases, and advancements in biobanking techniques. However, surveillance issues and storage problems hinder the growth of the Asia Pacific biobanks market.

The Asia Pacific Biobanks MarketSegmentsShare:

The Asia Pacific BiobanksMarket is categorised into by-product which consists of consumables, services, equipment, and software. Consumables have the most significant share due to the increase in some biobanks. By samples, Biobanksmarket is segmented as biological fluids, human tissues, blood products, and human waste products. Among all human tissues are expected to have high growth rate during the forecast period 2018-2024, because of increase in research. Drug discovery and analysis are leading in biobanks market among application due to the rise in technological advancements, research, and manufacturing of drugs.

By Geography, China is dominating the biobanks market, and the growth in the Asia Pacific is mainly attributed because of the increasing demand for personalised medicine and rise in cancer cases. Furthermore, India is witnessing the fastest growth during the forecast period, due to rising ageing population, chronic diseases and investment in R&D research.

The Asia Pacific BiobanksMarketSegmentsTrends:

• In a recent study, biological samples and genomic data an accelerate diagnosis and therapeutic research for the NGY1 deficiency.
• In May 2017, Thermo Fisher Scientific Inc.has been acquired with Patheon Contract Development and Manufacturing Company.

The Asia Pacific BiobanksResearch Report:

• An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
• To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
• Regional and the global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
• Identifying DROC in the current market and their impact in altering the market dynamics.
• Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
• Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
• Cryo Bio Systems
• Covance Inc.
• CryoXtract
• Tissue Solutions
• Stemcell Technologies Inc.
•